Diagnostics News and Research

RSS

Meridian Bioscience first quarter net sales decrease 12% to $37.3 million

Net sales for the first quarter of fiscal 2011 were $37,263,000 as compared to $42,457,000 for the same period of the prior fiscal year, a decrease of 12%. Net earnings for the first quarter of fiscal 2011 were $6,025,000, or $0.15 per diluted share, both decreases of 32% from the first quarter of fiscal 2010. Diluted common shares outstanding for the first quarter of fiscal 2011 and 2010 were 41,294,000 and 41,185,000, respectively.

20 Jan 2011

CHI responds to FDA recommendations for 510(k) regulatory review process

California Healthcare Institute today released a statement in response to new U.S. Food and Drug Administration (FDA) recommendations that could transform the 510(k) regulatory review process for new medical devices, greatly affecting innovation and public health in California.

20 Jan 2011

Medidata extends Grants Manager web-based budgeting application with new Contracting module

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today extended the Grants Manager® web-based budgeting application with a new Contracting module, enabling sites and sponsors to negotiate clinical trial site budgets directly online, eliminating the burden of managing hundreds of email messages and reducing budgeting cycle times.

20 Jan 2011

Finland begins implementation of European biomedical research infrastructures

Finland starts the implementation of European biomedical research infrastructures (BMS ESFRIs) by investing in a national effort called Biomedinfra - a joint effort linking to the EU level initiatives in developing biobanking (BBMRI), bioinformatics (ELIXIR), and translational research (EATRIS) infrastructures. This investment follows the 3-year pan-European planning phase, and a Finnish 2 M€ pilot project for Biomedinfra completed in 2010.

20 Jan 2011

QBC Diagnostics releases ParaLens Advance to provide benefits of LED fluorescence microscopy

QBC Diagnostics is pleased to announce the release of the QBC ParaLens Advance, a breakthrough product that can easily upgrade any compound light microscope for LED fluorescence microscopy.

20 Jan 2011

DARPA grants $5.6 million to Dana-Farber to develop viable countermeasures against unknown pathogen

Researchers at Dana-Farber Cancer Institute have received a $5.6 million grant from the Defense Advanced Research Projects Agency and the Army Research Office to develop transient immunity against known, unknown, naturally occurring, or engineered disease-causing pathogens.

20 Jan 2011

Home blood pressure monitors can help people keep blood pressure in check

A recent research review has concluded that home blood pressure monitors can help people keep their blood pressure in check and possibly cut down on medication – as long as patients and their doctors put those home readings to good use. For years, Omron Healthcare, Inc. has reminded Americans how important home blood pressure monitoring is when it comes to reducing their risk of a heart attack or stroke, and truly wants people to take the news to heart in 2011.

19 Jan 2011

Europe's leading oncology organisations receive €12 million grant to streamline cross border research

Europe's leading oncology organisations are combining forces in the global fight against cancer. The project, EurocanPlatform, has received €12 million from the European Union to streamline cross border research. The project will find moreeffective ways to ensure the prevention, early discovery and treatment of different forms of cancer.

19 Jan 2011

New patented technique offers unprecedented view of DNA damage

New technology providing the first view of DNA damage throughout the entire human genome developed by Cardiff University scientists could offer a valuable new insight into the development and treatment of conditions like cancer.

19 Jan 2011

RG7204 Phase III study shows significant survival benefit in patients with metastatic melanoma

Genentech, a member of the Roche Group, today announced that BRIM3, a Phase III clinical study of RG7204, met its co-primary endpoints showing a significant survival benefit in people with previously untreated BRAF V600 mutation-positive metastatic melanoma.

19 Jan 2011

New project on developing countermeasures for natural and intentional exposure to disease pathogens

Researchers at Dana-Farber Cancer Institute have received a $5.6 million grant from the Defense Advanced Research Projects Agency (DARPA) and the Army Research Office (ARO) to develop transient immunity against known, unknown, naturally occurring, or engineered disease-causing pathogens. The ultimate goal is to develop a viable countermeasure to an unknown pathogen within seven days of receiving it in a laboratory.

19 Jan 2011

Positive results from PLX4032 Phase 3 Trial in patients with metastatic melanoma

Plexxikon today announced positive data from an interim analysis of the BRIM3 trial, a large multi-center Phase 3 clinical study of PLX4032 in patients with previously untreated metastatic melanoma with the BRAF mutation. Patients treated with PLX4032 had an improved overall survival compared to patients treated with dacarbazine, the current standard of care.

19 Jan 2011

Revolution R Enterprise implemented at CardioDX

Revolution Analytics, the leading provider of commercial software and support for the popular open source R statistics language, today announced the successful implementation of its signature product, Revolution R Enterprise, by biostatisticians at CardioDX, a genomic research firm.

19 Jan 2011

iBio grants commercial, royalty-bearing license to Fiocruz/Bio-Manguinhos for new yellow fever vaccine

iBio, Inc. today announced the grant of a commercial, royalty-bearing license to Fiocruz/Bio-Manguinhos of Brazil to develop, manufacture and sell certain vaccines based upon iBio's proprietary technology. Fiocruz/Bio-Manguinhos will invest more than $6 million to bring the first product - a new yellow fever vaccine - through Phase I clinical trials.

18 Jan 2011

GE Healthcare becomes US distributor and reseller of Veran's ig4 navigation system

GE Healthcare and Veran, a provider of proprietary 4D registration capability for precise targeting of lesions via its FDA cleared platform, today announced a strategic supplier agreement in which GE Healthcare becomes the exclusive distributor and reseller of Veran's ig4 navigation system in the United States.

18 Jan 2011

Vasomedical second quarter total revenues increase 353% to $3.801 million

Vasomedical, Inc., a global provider of medical devices, today announced financial results of the three months ended November 30, 2010. Vasomedical is a world leader in the noninvasive treatment of cardiovascular diseases.

18 Jan 2011

Critical Diagnostics' Presage ST2 Assay effectively risk-stratifies chronic heart failure patients

Critical Diagnostics, the exclusive developer of the Presage® ST2 Assay, announces the publication of the Penn Heart Failure Study (PHFS) in an advance e-publication of the January 19, 2010 edition of Circulation: Heart Failure. The results of this study demonstrated that ST2 levels not only predict outcomes for ambulatory outpatients with chronic heart failure, they more effectively risk-stratify such patients.

18 Jan 2011

UCSF student wins 2010 Lucien Rubenstein Award

The American Brain Tumor Association (ABTA) has announced that Ryan Salinas, now a 2nd-year medical student at the University of California, San Francisco (UCSF), is the 2010 Lucien Rubenstein Award recipient. The work of Salinas, one of 10 ABTA Medical Student Summer Fellows in 2010, was deemed "outstanding" by the organization's distinguished Scientific Advisory Council.

14 Jan 2011

Cancer Research UK and CRT select 4 research groups to unravel role of cancer stem cells

Cancer Research UK and its commercial arm Cancer Research Technology (CRT), have established a team of scientists with expertise in cancer stem cell research to identify new targets to detect, monitor and treat cancer.

14 Jan 2011

Ortivus wins procurement order from Southern Älvsborgs Hospital, Sweden

Ortivus have won a procurement of patient monitoring equipment for the cardiology and emergency departments at Southern Älvsborgs Hospital in Borås, Sweden. Furthermore have orders in Italy and Norway been obtained that confirms Ortivus distributor and Value Added Reseller contracts in respective countries.

14 Jan 2011

Diagnostics News and Research

Meridian Bioscience first quarter net sales decrease 12% to $37.3 million

CHI responds to FDA recommendations for 510(k) regulatory review process

Medidata extends Grants Manager web-based budgeting application with new Contracting module

Finland begins implementation of European biomedical research infrastructures

QBC Diagnostics releases ParaLens Advance to provide benefits of LED fluorescence microscopy

DARPA grants $5.6 million to Dana-Farber to develop viable countermeasures against unknown pathogen

Home blood pressure monitors can help people keep blood pressure in check

Europe's leading oncology organisations receive €12 million grant to streamline cross border research

New patented technique offers unprecedented view of DNA damage

RG7204 Phase III study shows significant survival benefit in patients with metastatic melanoma

New project on developing countermeasures for natural and intentional exposure to disease pathogens

Positive results from PLX4032 Phase 3 Trial in patients with metastatic melanoma

Revolution R Enterprise implemented at CardioDX

iBio grants commercial, royalty-bearing license to Fiocruz/Bio-Manguinhos for new yellow fever vaccine

GE Healthcare becomes US distributor and reseller of Veran's ig4 navigation system

Vasomedical second quarter total revenues increase 353% to $3.801 million

Critical Diagnostics' Presage ST2 Assay effectively risk-stratifies chronic heart failure patients

UCSF student wins 2010 Lucien Rubenstein Award

Cancer Research UK and CRT select 4 research groups to unravel role of cancer stem cells

Ortivus wins procurement order from Southern Älvsborgs Hospital, Sweden

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News